150 related articles for article (PubMed ID: 38101783)
1. [Expression and clinical significance of plasma exosomal miR-34-5p and miR-142-3p in systemic sclerosis].
Li WG; Gu XD; Weng RQ; Liu SD; Chen C
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1022-1027. PubMed ID: 38101783
[TBL] [Abstract][Full Text] [Related]
2. microRNAs are potentially regulating the survivin gene in PBMCs from systemic sclerosis patients.
Ebrahimiyan H; Gharibdoost F; Aslani S; Kavosi H; Farsad F; Jamshidi A; Mahmoudi M
Mod Rheumatol; 2020 Sep; 30(5):862-869. PubMed ID: 31441344
[No Abstract] [Full Text] [Related]
3. miR-155 in the progression of lung fibrosis in systemic sclerosis.
Christmann RB; Wooten A; Sampaio-Barros P; Borges CL; Carvalho CR; Kairalla RA; Feghali-Bostwick C; Ziemek J; Mei Y; Goummih S; Tan J; Alvarez D; Kass DJ; Rojas M; de Mattos TL; Parra E; Stifano G; Capelozzi VL; Simms RW; Lafyatis R
Arthritis Res Ther; 2016 Jul; 18(1):155. PubMed ID: 27377409
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-542-3p Contributes to Apoptosis Resistance in Dermal Fibroblasts from Systemic Sclerosis Patients via Survivin Overexpression.
Vahidi Manesh P; Farazmand A; Gharibdoost F; Vanaki N; Mostafaei S; Kavosi H; Mahmoudi MB; Mahmoudi M
Iran J Allergy Asthma Immunol; 2019 Apr; 18(2):173-181. PubMed ID: 31066253
[TBL] [Abstract][Full Text] [Related]
5. Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension.
Wuttge DM; Carlsen AL; Teku G; Wildt M; Rådegran G; Vihinen M; Heegaard NHH; Hesselstrand R
Rheumatology (Oxford); 2021 Dec; 61(1):309-318. PubMed ID: 33784391
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of exosomal microRNAs in fresh and senescent apheresis platelet concentrates.
Mi Z; Gong L; Kong Y; Zhao P; Yin Y; Xu H; Tian L; Liu Z
Platelets; 2022 Nov; 33(8):1260-1269. PubMed ID: 35968647
[TBL] [Abstract][Full Text] [Related]
7. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis and microRNA expression profiling of plasma-derived exosomes in primary immune thrombocytopenia.
Sun Y; Hou Y; Meng G; Han P; Zhao Y; Wang H; Xu M; Wang Y; Qiu J; Peng J; Shao L; Sun L; Hou M
Br J Haematol; 2021 Sep; 194(6):1045-1052. PubMed ID: 34337736
[TBL] [Abstract][Full Text] [Related]
9. Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures.
Dolcino M; Pelosi A; Fiore PF; Patuzzo G; Tinazzi E; Lunardi C; Puccetti A
Front Immunol; 2018; 9():449. PubMed ID: 29559981
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-320a: an important regulator in the fibrotic process in interstitial lung disease of systemic sclerosis.
Li Y; Huang J; Hu C; Zhou J; Xu D; Hou Y; Wu C; Zhao J; Li M; Zeng X; Liu C; Wang Q; Zhao Y
Arthritis Res Ther; 2021 Jan; 23(1):21. PubMed ID: 33430962
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implication of downregulated exosomal miRNAs in patients with sepsis: a cross-sectional study with bioinformatics analysis.
Shin B; Lee JY; Im Y; Yoo H; Park J; Lee JS; Lee KY; Jeon K
J Intensive Care; 2023 Aug; 11(1):35. PubMed ID: 37537685
[TBL] [Abstract][Full Text] [Related]
12. Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis.
Chouri E; Servaas NH; Bekker CPJ; Affandi AJ; Cossu M; Hillen MR; Angiolilli C; Mertens JS; van den Hoogen LL; Silva-Cardoso S; van der Kroef M; Vazirpanah N; Wichers CGK; Carvalheiro T; Blokland SLM; Giovannone B; Porretti L; Marut W; Vigone B; van Roon JAG; Beretta L; Rossato M; Radstake TRDJ
J Autoimmun; 2018 May; 89():162-170. PubMed ID: 29371048
[TBL] [Abstract][Full Text] [Related]
13. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNAs in Systemic Sclerosis, Associations with Digital Vasculopathy and Lung Involvement.
Wajda A; Walczyk M; Dudek E; Stypińska B; Lewandowska A; Romanowska-Próchnicka K; Chojnowski M; Olesińska M; Paradowska-Gorycka A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142646
[No Abstract] [Full Text] [Related]
15. Plasma-derived exosomal let-7c-5p, miR-335-3p, and miR-652-3p as potential diagnostic biomarkers for stable coronary artery disease.
Han J; Cui X; Yuan T; Yang Z; Liu Y; Ren Y; Wu C; Bian Y
Front Physiol; 2023; 14():1161612. PubMed ID: 37228823
[No Abstract] [Full Text] [Related]
16. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
[TBL] [Abstract][Full Text] [Related]
17. Plasma-Derived Exosomal hsa-miR-4488 and hsa-miR-1228-5p: Novel Biomarkers for Dermatomyositis-Associated Interstitial Lung Disease with Anti-Melanoma Differentiation-Associated Protein 5 Antibody-Positive Subset.
Zhong D; Wu C; Xu D; Bai J; Wang Q; Zeng X
Biomed Res Int; 2021; 2021():6676107. PubMed ID: 34368354
[TBL] [Abstract][Full Text] [Related]
18. Exosomal microRNA signatures in multiple sclerosis reflect disease status.
Ebrahimkhani S; Vafaee F; Young PE; Hur SSJ; Hawke S; Devenney E; Beadnall H; Barnett MH; Suter CM; Buckland ME
Sci Rep; 2017 Oct; 7(1):14293. PubMed ID: 29084979
[TBL] [Abstract][Full Text] [Related]
19. A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome.
Bozzini S; Zanframundo G; Bagnera C; Bozza E; Lettieri S; Vertui V; Codullo V; Cuzzocrea F; Atienza-Mateo B; Remuzgo Martinez S; Montecucco C; González-Gay MA; Cavagna L; Meloni F
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498905
[TBL] [Abstract][Full Text] [Related]
20. Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study.
Vandecasteele E; Melsens K; Vanhaecke A; Blockmans D; Bonroy C; Carton C; Deschepper E; De Keyser F; Houssiau F; Piette Y; Vanthuyne M; Verbeke K; Westhovens R; Wuyts WA; De Langhe E; Brusselle G; Smith V
Semin Arthritis Rheum; 2021 Oct; 51(5):969-976. PubMed ID: 34403812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]